🇺🇸 FDA
Patent

US 11560356

Compounds and compositions for the treatment of cancer

granted A61PA61P19/04A61P35/00

Quick answer

US patent 11560356 (Compounds and compositions for the treatment of cancer) held by The Regents of the University of California expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P19/04, A61P35/00, A61P43/00